药明康德

Happy #WorldCitiesDay!   Our global presence spans diverse cities, each playing a vital role in advancing health innovation. Today, we celebrate not just the cities where we operate, but the incredible people who make it all possible.   Worldwide, our employees are sharing what they cherish about WuXi AppTec in their native languages. Their messages reflect our unwavering commitment to delivering life-saving treatments and making a meaningful impact for patients.   WuXi AppTec is a proud global community dedicated to advancing the future of healthcare.   Let's keep building a healthier world together.

Thank you, Frost & Sullivan, for awarding us the 2024 Global Contract Research, Development and Manufacturing Organization Company of the Year Award. This is a proud moment for us! This marks the 8th consecutive year that WuXi AppTec has received this award. We are deeply honored by the recognition, which underscores how we meet customers’ needs through our comprehensive #CRDMO model. By continuously enhancing our capabilities and capacity, we support seamless drug development from discovery to commercialization, enabling the industry to bring more groundbreaking therapies to patients around the world. https://lnkd.in/e-suw_fP

WuXi AppTec's 2024 Investor Day was an incredible success. I’m grateful to Florence Shi, Edward Hu and Minzhang Chen for organizing such an outstanding event. Each year, we must be sensitive to trends to embrace the future – adapting our capabilities to drive innovation and sustain development. By generating flow, understanding trends, and providing coordinated capabilities, we create significant value for our customers. To our investors and talented individuals around the company, your contributions and collaboration are invaluable as we continue to deliver for patients. https://lnkd.in/gkAvkFJE

We recently broke ground in #Singapore!   Projected to start operations in 2027, our new Singapore site will offer API manufacturing for small molecules, oligonucleotides, peptides, and complex chemical conjugates, enhancing WuXi AppTec’s #CRDMO enabling platform. We look forward to continuing to support our customers worldwide in bringing more innovative treatments to patients in need.

Our mission goes beyond advancing healthcare innovations; we are equally dedicated to protecting the planet we all share🌱  Recently, our San Diego office proudly participated in Coastal Cleanup Day, organized by the nonprofit organization I Love A Clean San Diego, joining thousands of volunteers to clean the local beaches and support the global effort to safeguard our oceans. Together, we walked along the beautiful San Diego coastline, covering 5 kilometers (3.1 miles) and collecting 121 kilograms (267 pounds) of marine debris. As one of the largest corporate teams involved, we’re proud to have played a part in reducing plastic waste to preserve our environment for future generations.   This effort is a reflection of WuXi AppTec’s broader commitment to supporting the communities where we operate. Across our 32 global sites, our teams are driving positive change – not just through breakthrough therapies, but through meaningful contributions to local economies and environmental sustainability as well. #CoastalCleanup #Sustainability 

Meet Charles Brown, MS, Business Development Director at WuXi STA. From college football to the pharmaceutical industry, his journey reflects the discipline, hard work, and teamwork that he brings to every partnership at WuXi STA. "I'm proud to be part of a team that values doing the right thing and doing it right," says Charles. At WuXi STA, our commitment to quality, integrity, and a customer-first approach is at the heart of everything we do. #WuXiAppTec #MeetOurPeople #InnovationInHealthcare

Our commitment to social responsibility extends far beyond the lab. In honor of #InternationalDayofCharity, we are  proud to highlight our St. Paul site's 25th blood drive. Supported by our generous colleagues, the annual tradition collected 23 units of donated blood—each unit potentially saving up to 3 lives. Since 2019, our St. Paul team has collected 479 units, demonstrating our commitment to making a meaningful impact. This program is just one example of how our global workforce contributes to a healthier world, reinforcing our mission to enable life-saving #innovations. #LifeSciences #healthcare 

We are pleased to announce that WuXi AppTec has maintained its AA #MSCI ESG rating for the fourth consecutive year! The rating reflects WuXi AppTec’s commitment to incorporating environmental and social responsibilities into the company’s business strategies and operations. As an enabler of innovation, a trusted partner, and a contributor to the global pharmaceutical and life sciences industry, WuXi AppTec’s outstanding #ESG performance has been widely acknowledged by major global ESG rating agencies, including CDP, EcoVadis, S&P and Sustainalytics. https://lnkd.in/gT4Cwq7F

Take a look at our pioneering #CRDMO model.   Through the platform, we enable scientific innovations, develop distinct industry insights, quickly adapt to opportunities in new molecules as they rise, and continue to drive solid business growth. See how we’re accelerating the delivery of life-saving therapies and benefitting patients across the globe ⬇️   #Innovation #LifeSaving 

Our #H1Report performance demonstrates that our unique integrated #CRDMO business model can effectively meet the growing demand of customers worldwide.    We’re committed to continuously enhancing our capabilities and capacity to bring groundbreaking therapies to patients around the world.   See how we’re “doing the right thing and doing it right”: https://lnkd.in/ef-rsnzr